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Introduc)on.	  Although	  considered	  as	  a	  ﬁrst-­‐group	  carcinogen,	  indoor	  tanning	  is	  a	  common	  
prac7ce	  in	  Europe.	  Euromelanoma	  is	  a	  pan-­‐European	  skin	  cancer	  preven7on	  campaign.	  	  
	  
Objec)ve.	   To	   compare	   several	   European	   countries	   in	   terms	   of	   prevalence	   and	  
determinants	  of	  sunbed	  use.	  	  
	  
Materials	   and	   Methods.	   Par7cipants	   in	   the	   Euromelanoma	   campaigns	   ﬁlled	   in	  
ques7onnaires	   containing	   demographics	   and	   risk	   factors,	   including	   type/dura7on	   of	  
sunbed	  use.	  Mul7variate	  analyses	  adjusted	  for	  age,	  gender,	  educa7on,	  skin	  type,	  and	  year	  
of	   survey	  were	  employed	   to	  assess	   factors	   independently	   associated	  with	   sunbed	  use	   in	  
each	  country.	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association only partly. Indeed, our multivariate analysis
excluded a large effect of educational attainment on sunbed use.
This might represent an indication that indoor tanning –tradi-
tionally associated with higher socio-economic sta-
tus20,27,55,59,60,66,67– has started to transcend educational level
and possibly social class in Europe, as previously suggested.21,34
In line with previous data,45,47,48,50,55,60 we found that sunbed
use was more prevalent in darker skin types. However, the
prevalence of use in skin types I–II was non-negligible for
several countries, in accordance with other previous observa-
tions.20,23,51,60
The strengths of the study are that: it is the first investi-
gation ever comparing 30 European countries in terms of
prevalence/determinants of sunbed use; the sample size was
extremely large; the same questionnaire was used in all
participating countries; and multivariate models were used
to find independent determinants of sunbed use. The obvi-
ous limitation is that the study was not population-based,
but carried out within a skin cancer screening campaign.
This might have not only selected a population more
responsible towards indoor tanning (selection bias), but also
induced participants to under-report a ‘bad’ habit, in order
to feel less guilty and please their doctors (social desirability
bias). Moreover, skin type was self-reported and we cannot
exclude that sunbed users wanted to perceive themselves as
darker and therefore reported a darker skin type (reporting
bias). Another limitation was that latitude, sunshine and
wealth measures were only available for the country as a
whole and not for the individual subjects, since the survey
did not enquire about city of residence nor personal income
Table 3 Prevalence of sunbed use for the 30 participating countries, according to age group (adolescents, young adults, adult/elderly)
Age <20 years Age 20–35 years Age >35 years P-value* P-value†
% 95% CI % 95% CI % 95% CI
Belgium 26.5 24.1–28.9 30.0 28.1–31.9 25.2 24.1–26.3 <0.001 <0.001
Bosnia-Herzegovina 4.0 2.6–6.0 11.2 9.9–12.6 2.2 1.8–2.7 <0.001 <0.001
Croatia 3.9 2.2–6.5 23.2 20.8–25.7 9.2 8.2–10.3 0.01 <0.001
Cyprus – – 15.4 1.9–45.5 – – – –
Czech Republic 7.2 6.0–8.6 21.9 20.8–23.1 5.7 5.3–6.2 0.001 <0.001
Denmark 23.9 15.6–33.9 36.0 31.6–40.7 20.9 19.0–23.0 0.30 <0.001
Estonia 11.4 6.5–18.1 33.4 28.4–38.8 13.3 11.1–15.7 0.06 <0.001
Georgia 0.4 0.0–2.2 4.8 3.1–6.9 0.6 0.3–1.0 0.99 <0.001
Germany 11.9 9.4–14.8 18.9 16.6–21.4 8.8 8.0–9.5 0.02 <0.001
Greece 1.5 1.1–2.0 4.5 4.1–4.9 2.3 2.1–2.6 <0.001 <0.001
Hungary 10.6 8.9–12.6 33.4 31.9–35.0 15.0 14.2–15.9 0.08 <0.001
Ireland 15.0 3.2–37.9 10.0 3.3–21.8 13.6 9.2–19.2 0.28 0.76
Italy 5.9 3.7–9.0 32.4 28.9–35.9 18.9 17.3–20.6 <0.001 <0.001
Latvia 16.9 11.8–23.2 46.8 42.7–51.0 15.7 13.7–18.0 0.03 <0.001
Lithuania 11.3 9.0–14.0 34.2 31.8–36.8 6.9 6.0–7.8 <0.001 <0.001
Macedonia (FYROM) 4.1 1.7–8.2 12.2 9.0–16.1 1.2 0.5–2.2 <0.001 <0.001
Malta – – – – 0.6 0.1–2.2 – –
Moldova – – – – 5.3 0.6–17.8 – –
Norway 33.3 13.3–59.0 32.3 26.8–38.3 19.1 16.6–21.8 0.08 <0.001
Poland 7.0 5.4–9.0 23.1 21.4–24.8 12.0 10.9–13.1 <0.001 <0.001
Portugal 1.6 1.0–2.5 4.5 3.5–5.6 1.2 0.9–1.5 0.88 <0.001
Romania 6.5 4.9–8.5 10.3 8.0–13.1 3.5 2.5–4.7 0.02 <0.001
Russia 7.1 5.7–8.7 20.9 19.5–22.3 5.3 4.8–5.9 <0.001 <0.001
Serbia 9.5 7.8–11.3 19.1 17.4–20.8 6.4 5.8–7.2 0.002 <0.001
Slovenia – 10.8 7.0–15.8 4.6 3.0–6.7 – 0.003
Spain 16.6 14.5–18.9 29.5 26.4–32.6 16.5 14.8–18.2 <0.001 <0.001
Sweden 23.5 19.6–27.7 23.1 21.4–24.8 15.5 14.9–16.1 <0.001 <0.001
Switzerland 5.5 4.2–7.1 12.9 11.9–14.0 8.3 7.8–8.8 0.01 <0.001
Turkey 1.8 0.4–5.1 1.3 0.5–2.7 0.6 0.2–1.5 0.09 0.14
Ukraine 2.6 1.9–3.5 7.0 6.1–8.0 0.9 0.7–1.2 <0.001 <0.001
*P value refers to the comparison between the <20 years and the >35 years groups.
†P value refers to the comparison between the 20–35 years and the >35 years groups. Differences could not be assessed for Cyprus (all users young
adult), Malta (all users adults/elderly), Moldova (all users adults/elderly) and Slovenia (no adolescent users).
Age groups were compared by means of multivariate models also including gender, education, skin type and year of survey.
Signiﬁcant ﬁndings are highlighted in bold.
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Table 4 Prevalence of sunbed use for the 30 participating countries according to gender, education and skin type
A. Gender B. Education C. Skin type
Females Males P Ratio F/M High education Low education P Skin type III–VI Skin type I–II P
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
Belgium 34.6 33.4–35.8 13.1 12.0–14.3 <0.001 2.6 25.5 24.4–26.6 28.1 26.5–29.6 <0.001 28.6 27.5–29.8 23.1 21.8–24.5 <0.001
Bosnia-Herzegovina 7.3 6.5–8.1 1.1 0.7–1.6 <0.001 6.6 6.5 5.8–7.4 3.5 2.8–4.2 0.002 5.4 4.8–6.0 4.3 3.4–5.4 0.10
Croatia 17.6 16.2–19.0 2.8 2.0–3.8 <0.001 6.3 15.2 13.6–16.9 10.4 9.2–11.7 0.21 12.7 11.6–13.9 11.8 9.9–14.0 0.01
Cyprus 7.7 0.2–36.0 – – – – – – 11.1 1.4–34.7 – – – 8.0 1.0–26.0 –
Czech Rep. 13.7 13.1–14.4 3.9 3.4–4.5 <0.001 3.5 12.0 10.7–13.3 10.6 9.9–11.4 0.62 11.4 10.9–12.0 7.4 6.6–8.2 <0.001
Denmark 28.3 26.0–30.7 15.4 12.7–18.4 <0.001 1.8 26.3 23.9–28.7 19.5 16.7–22.6 <0.001 23.8 21.8–25.9 24.0 20.3–28.1 0.20
Estonia 21.7 19.2–24.4 7.3 4.7–10.7 <0.001 3 19.6 17.0–22.5 17.8 14.1–22.0 0.48 18.3 15.3–21.6 17.5 14.8–20.5 0.53
Georgia 1.7 1.2–2.4 0.5 0.1–1.3 0.08 3.4 1.6 1.1–2.2 0.7 0.2–1.8 0.78 1.6 1.1–2.3 0.5 0.1–1.4 0.06
Germany 13.0 12.0–14.0 6.4 5.5–7.4 <0.001 2 9.8 8.9–10.9 11.2 10.1–12.4 0.01 11.6 10.8–12.5 6.6 5.5–7.9 <0.001
Greece 4.3 4.0–4.6 0.9 0.7–1.1 <0.001 4.8 3.6 3.3–3.8 1.6 1.3–1.9 <0.001 3.0 2.8–3.3 3.1 2.7–3.4 0.25
Hungary 25.0 24.1–25.9 7.6 6.7–8.6 <0.001 3.3 22.7 21.7–23.8 18.9 17.9–20.0 0.02 21.6 20.7–22.5 17.0 15.8–18.3 <0.001
Ireland 16.3 11.1–22.7 7.7 3.2–15.2 0.02 2.1 11.1 6.6–17.2 16.2 9.7–24.7 0.39 13.6 9.0–19.4 12.6 6.7–21.0 0.31
Italy 25.8 23.9–27.8 12.3 10.6–14.3 <0.001 2.1 24.3 21.7–27.1 19.2 17.6–21.0 0.69 19.8 18.2–21.4 21.3 18.6–24.1 0.94
Latvia 29.1 26.8–31.5 10.4 7.6–13.8 <0.001 2.8 26.5 24.3–28.9 22.0 18.0–26.4 0.65 28.7 25.6–32.0 22.2 19.8–24.7 <0.001
Lithuania 18.5 17.3–19.8 5.2 4.2–6.5 <0.001 3.6 15.2 14.1–16.3 13.9 11.9–16.2 0.81 16.0 14.9–17.2 10.9 9.4–12.6 <0.001
Macedonia (FYROM) 6.4 4.8–8.2 1.3 0.5–2.9 0.01 4.9 6.9 5.1–9.0 1.8 0.9–3.3 0.01 5.7 4.2–7.5 2.8 1.5–4.7 0.10
Malta 0.8 0.1–3.0 – – – – 0.6 0.0–3.4 0.4 0.0–2.3 0.35 0.4 0.0–2.2 0.6 0.0–3.1 0.99
Moldova 5.1 0.6–17.3 – – – – 4.8 0.6–16.2 – – – 4.7 0.6–15.8 – – –
Norway 27.4 24.2–30.8 14.1 11.2–17.6 <0.001 1.9 22.6 20.0–25.3 20.1 15.1–25.9 0.91 22.7 20.1–25.4 19.5 14.4–25.5 0.02
Poland 19.6 18.4–20.8 6.3 5.3–7.4 <0.001 3.1 16.5 15.4–17.6 13.4 12.0–14.9 0.50 16.3 15.3–17.3 11.8 10.2–13.5 <0.001
Portugal 2.5 2.1–3.0 1.1 0.7–1.5 <0.001 2.3 1.9 1.3–2.3 1.8 1.4–2.4 0.03 1.9 1.5–2.4 2.0 1.6–2.6 0.62
Romania 8.3 7.0–9.7 1.8 1.1–3.0 <0.001 4.6 6.3 5.0–7.9 5.8 4.5–7.2 0.94 6.3 5.2–7.5 5.4 4.0–7.1 0.29
Russia 11.1 10.5–11.8 4.1 3.2–5.1 <0.001 2.7 11.7 11.0–12.4 6.1 5.2–7.1 <0.001 11.2 10.6–11.9 7.0 6.2–7.9 <0.001
Serbia 13.3 12.4–14.2 3.0 2.3–3.7 <0.001 4.4 11.6 10.7–12.7 8.6 7.8–9.5 0.003 10.4 9.7–11.2 9.3 8.1–10.6 0.003
Slovenia 8.6 6.3–11.5 2.2 0.9–4.4 <0.001 3.9 7.1 4.9–9.9 4.3 2.5–7.1 0.51 6.5 4.7–8.7 4.1 1.7–8.2 0.12
Spain 25.1 23.4–26.8 8.8 7.4–10.4 <0.001 2.9 23.1 21.5–24.8 12.4 10.7–14.3 <0.001 20.1 18.4–21.9 18.6 16.9–20.4 0.02
Sweden 21.5 20.7–22.3 8.1 7.4–8.8 <0.001 2.7 17.1 16.4–17.9 16.5 15.5–17.5 0.95 17.4 16.7–18.0 14.4 13.2–15.6 <0.001
Switzerland 11.5 10.9–12.1 6.0 5.5–6.6 <0.001 1.9 10.0 9.5–10.6 7.1 6.4–7.9 0.005 8.9 8.4–9.4 9.2 8.5–10.0 0.03
Turkey 1.4 0.7–2.4 0.4 0.1–1.5 0.08 3.5 1.4 0.7–2.5 0.5 0.1–1.6 0.28 1.0 0.5–2.0 0.9 0.3–2.1 0.70
Ukraine 3.2 2.8–3.6 0.7 0.5–1.1 <0.001 4.6 2.7 2.4–3.1 1.5 1.1–2.0 0.002 2.6 2.3–2.9 1.8 1.4–2.4 0.01
Groups were compared by means of multivariate models including age, gender, education, skin type and year of survey.
Signiﬁcant ﬁndings are highlighted in bold. Differences could not be ascertained for Cyprus (all users females, with low education and skin type I–II), Malta (all users females) and Moldova (all users
females, with high education and skin type III–VI).






























Results.	   In	   total,	   227,888	   individuals	   (67.4%	   females,	   median	   age	   44,	   63.4%	   highly	  
educated,	   71.9%	   skin	   types	   III-­‐VI)	   from	   30	   countries	   par7cipated.	   Overall	   prevalence	   of	  
sunbed	   ever-­‐use	   was	   10.6%	   (≤19-­‐year-­‐olds:	   5.9%;	   20	   to	   35-­‐year-­‐olds:	   17.0%;	   >35-­‐year-­‐
olds:	   8.3%).	   Sunbed	   use	   prevalence	   was	   higher	   in	   northern,	   sun-­‐deprived	   countries:	  
signiﬁcant	  correla7ons	  were	  found	  between	  sunbed	  use	  prevalence	  and	  countries’	  la7tude	  
(p<0.001)	   and	   sunshine	   (p=0.002);	   Italy	   and	   Spain	   represented	   excep7ons	   towards	  
excessive	   exposure	   (Figure	   1).	   Females	   displayed	   higher	   prevalence	   than	   males	   in	   all	  
countries.	   Balkan	   countries	   displayed	   the	   highest	   female/male	   ra7os	   (≥4)	   (Table	   1A).	  
Sunbed	  use	  was	   signiﬁcantly	  more	  prevalent	  among	  highly	  educated	  par7cipants	   (11/30	  
countries)	   (Table	   1B)	   and	   skin	   type	   III-­‐VI	   (14/30	   countries)	   (Table	   1C).	   Very	   diﬀerent	  
prevalence	  rates	  were	  found	  for	  Spain	  (19.3%)	  and	  Portugal	  (2.0%).	  Scandinavian	  countries	  
ranked	  highest	  in	  sunbed	  use	  among	  ≤19-­‐year-­‐olds,	  Bal7c	  countries	  among	  20	  to	  35-­‐year-­‐
olds	  (Table	  2).	  	  
Table	  1.	  Prevalence	  of	  sunbed	  use	  for	  the	  30	  par)cipa)ng	  countries	  according	  to	  gender,	  educa)on,	  and	  skin	  type.	  
Groups	  were	  compared	  by	  means	  of	  mul7variate	  models	  including	  age,	  gender,	  educa7on,	  skin	  type,	  and	  year	  of	  survey.	  Signiﬁcant	  ﬁndings	  are	  
highlighted	   in	  bold.	  Diﬀerences	   could	  not	  be	  ascertained	   for	  Cyprus	   (all	   users	   females,	  with	   low	  educa7on	  and	   skin	   type	   I-­‐II),	  Malta	   (all	   users	  
females)	  and	  Moldova	  (all	  users	  females,	  with	  high	  educa7on	  and	  skin	  type	  III-­‐VI).	  FYROM,	  Former	  Yugoslav	  Republic	  of	  Macedonia	  
Table	   2.	   Prevalence	   of	   sunbed	   us 	   for	   the	   30	   par)cipa)n 	   countries,	   according	   to	   age	   group	   (adolescents,	   young	  
adults,	  adul /elderly).	  	  
Age	  groups	  were	  compared	  by	  means	  of	  mul7variate	  mod ls	  also	  i cluding	  gender,	  edu a7on,	  skin	  type	  and	  year	  of	  survey.	  *p	  value	  refers	  to	  
the	  comparison	  between	  the	  <20	  years	  and	  the	  >35	  years	  groups.	  †p	  value	  refers	  to	  the	  comparison	  between	  the	  20-­‐35	  years	  and	  the	  >35	  years	  
groups.	  Diﬀerences	  could	  not	  be	  assessed	  for	  Cyprus	  (all	  users	  young	  adult),	  Malta	  (all	  users	  adults/elderly),	  Moldova	  (all	  users	  adults/elderly)	  
and	  Slovenia	  (no	  adolescent	  users).	  Signiﬁcant	  ﬁndings	  are	  highlighted	  in	  bold.	  FYROM,	  Former	  Yugoslav	  Republic	  of	  Macedonia	  
Figure	  4.	  Geographic	  par)culari)es	  of	  sunbed	  use	  in	  Europe:	  Iberian	  par*cularity,	  prevalence	  of	  ever	  use	  was	  10	  )mes	  
higher	  in	  Spain	  than	  in	  Portugal;	  Balkan	  par*cularity,	  prevalence	  of	  ever	  use	  was	  dispropor)onally	  in	  favour	  of	  
women;	  Bal*c	  par*cularity,	  the	  highest	  prevalence	  of	  ever	  use	  among	  young	  adults;	  Scandinavian	  par*cularity,	  the	  
highest	  prevalence	  of	  ever	  use	  among	  adolescents.	  
Figure	  1.	  Prevalence	  of	  ever	  use	  of	  sunbed	  in	  the	  30	  par)cipa)ng	  countries.	  Countries	  were	  grouped	  in	  ter)les	  based	  
on	  the	  distribu)on	  of	  their	  prevalence	  of	  sunbed	  use.	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  A	  Girnita:	  Theme	  Cancer,	  Karolinska	  Ins7tute	  and	  Karolinska	  University	  Hospital,	  Stockholm,	  
Sweden;	  J	  Hafner:	  Department	  of	  Dermatology,	  University	  Hospital	  of	  Zürich,	  Zürich,	  Switzerland;	  J	  Hercogová:	  Dermatovenereology	  Department,	  2nd	  Medical	  Faculty,	  Charles	  University,	  Bulovka	  Hospital,	  Prague,	  Czech	  Republic;	  P	  Konno:	  Dermatology	  Outpa7ent	  Clinic,	  Clinic	  of	   Internal	  Medicine,	  East	  Tallinn	  Central	  Hospital,	  Tallinn,	  
Estonia;	  HF	  Lorentzen:	  Department	  of	  Dermatology,	  Aarhus	  University	  Hospital,	  Aarhus,	  Denmark;	  T	  Maselis:	  Private	  Prac7ce,	  Tienen,	  Belgium;	  L	  Medenica:	  Department	  of	  Dermatology	  and	  Venereology,	  School	  of	  Medicine,	  University	  of	  Belgrade,	  Belgrade,	  Serbia;	  L	  Mekokishvili:	  Faculty	  of	  Medicine,	  Caucasus	  Interna7onal	  University,Tbilisi,	  
Georgia;	  M	  Murphy:	  Dermatology	  Department,	  South	  Inﬁrmary	  Victoria	  University	  Hospital,	  Cork,	  Ireland;	  B	  Nedelciuc:	  Department	  of	  Dermatovenerology,	  "Nicolae	  Testemitanu"	  State	  Univ rsity	  of	  Medicine	  and	  Pharmacy,	  Chisinau,	  Republic	  of	  Mol ova;	  AC	  Nicolescu:	  Department	  of	  Dermatology	  –	  CDT	  Roma,	  Buchares ,	  Romania;	  J	  Oláh:	  
Department	  of	  Dermatology	  and	  Allergology,	  University	  of	  Szeged,	  Szeged,	  Hungary;	  N	  Onsun:	  Department	  of	  Dermatology,	  School	  of	  Medicine,	  Bezmialem	  Vakif	  University,	  Istanbul,	  Turkey;	  A	  Pallouras:	  Department	  of	  Dermatology,	  Cyprus	  Society	  of	  Dermatology	  and	  Venereology,	  Larnaca,	  Cyprus;	  W	  Placek:	  Department	  of	  Dermatology,	  
Sexually	  Transmised	  Diseases	  and	  Clinical	  Immunology,	  University	  of	  Warmia	  and	  Mazury,	  Olsztyn,	  Poland;	  N	  Potekaev:	  Moscow	  Scien7ﬁc	  and	  Prac7cal	  Center	  of	  Dermatovenereology	  and	  Cosmetology,	  Moscow,	  Russia;	  M	  Reusch:	  Dermatological	  Prac7ce	  Tibarg,	  Hamburg,	  Germany;	  I	  Roscher:	  Department	  of	  Dermatology,	  Oslo	  University	  
Hospital,	  Oslo,	  Norway;	  T	  Planinšek	  Ručigaj:	  Dermatovenereological	  Clinic,	  University	  Medical	  Centre	  Ljubljana,	  Ljubljana,	  Slovenia;	  L	  Scerri:	  Department	  of	  Dermatology	  &	  Venereology,	  Sir	  Paul	  Boﬀa	  Hospital,	  Floriana,	  Malta;	  M	  Šitum:	  University	  Department	  of	  Dermatovenereology,	  University	  Hospital	  “Sestre	  milosrdnice”,	  Zagreb,	  Croa7a;	  Z	  
Zaﬁrovik:	  University	  Clinic	  of	  Dermatology,	  Medical	  Faculty,	  University	  “St.	  Cyril	  and	  Methodius”,	  Skopje,	  Former	  Yugoslav	  Republic	  of	  Macedonia	  (FYROM).	  
Conclusions.	  The	  main	  determinants	  of	   sunbed	  use	  were	  age	   (young	  adults)	  and	  gender	  
(females),	   whereas	   educa7on	   and	   skin	   type	   had	   a	   less	   relevant	   eﬀect.	   Geographic	  
par7culari7es	  were	   found	   in	   four	   regions:	   Iberian	   (prevalence	   ten	   7mes	   higher	   in	   Spain	  
than	   Portugal),	   Balkan	   (prevalence	   dispropor7onately	   higher	   among	   women),	   Bal7c	  
(highest	   prevalence	   among	   young	   adults),	   and	   Scandinavian	   (highest	   prevalence	   among	  
adolescents)	   (Figure	  2).	  These	  data	  have	  public	  health	  relevance	   for	   future	   interven7ons	  
aimed	  at	  reducing	  sunbed	  use	  in	  Europe.	  
